326 related articles for article (PubMed ID: 2458130)
1. The heparin binding domain of S-protein/vitronectin binds to complement components C7, C8, and C9 and perforin from cytolytic T-cells and inhibits their lytic activities.
Tschopp J; Masson D; Schäfer S; Peitsch M; Preissner KT
Biochemistry; 1988 May; 27(11):4103-9. PubMed ID: 2458130
[TBL] [Abstract][Full Text] [Related]
2. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
Tschopp J; Chonn A; Hertig S; French LE
J Immunol; 1993 Aug; 151(4):2159-65. PubMed ID: 8345200
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the lytic activity of perforin (cytolysin) and of late complement components by proteoglycans.
Tschopp J; Masson D
Mol Immunol; 1987 Sep; 24(9):907-13. PubMed ID: 3498887
[TBL] [Abstract][Full Text] [Related]
4. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
Milis L; Morris CA; Sheehan MC; Charlesworth JA; Pussell BA
Clin Exp Immunol; 1993 Apr; 92(1):114-9. PubMed ID: 7682159
[TBL] [Abstract][Full Text] [Related]
5. The pore-forming protein (perforin) of cytolytic T lymphocytes is immunologically related to the components of membrane attack complex of complement through cysteine-rich domains.
Young JD; Liu CC; Leong LG; Cohn ZA
J Exp Med; 1986 Dec; 164(6):2077-82. PubMed ID: 3537195
[TBL] [Abstract][Full Text] [Related]
6. Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis.
Tschopp J; Masson D; Stanley KK
Nature; 1986 Aug 28-Sep 3; 322(6082):831-4. PubMed ID: 2427956
[TBL] [Abstract][Full Text] [Related]
7. Complement inhibition by human vitronectin involves non-heparin binding domains.
Sheehan M; Morris CA; Pussell BA; Charlesworth JA
Clin Exp Immunol; 1995 Jul; 101(1):136-41. PubMed ID: 7542572
[TBL] [Abstract][Full Text] [Related]
8. Functional studies of the MACPF domain of human complement protein C8alpha reveal sites for simultaneous binding of C8beta, C8gamma, and C9.
Slade DJ; Chiswell B; Sodetz JM
Biochemistry; 2006 Apr; 45(16):5290-6. PubMed ID: 16618117
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
Brannen CL; Sodetz JM
Mol Immunol; 2007 Feb; 44(5):960-5. PubMed ID: 16624411
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
11. Interaction between the C8 alpha-gamma and C8 beta subunits of human complement C8: role of the C8 beta N-terminal thrombospondin type 1 module and membrane attack complex/perforin domain.
Musingarimi P; Plumb ME; Sodetz JM
Biochemistry; 2002 Sep; 41(37):11255-60. PubMed ID: 12220191
[TBL] [Abstract][Full Text] [Related]
12. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9.
Ninomiya H; Sims PJ
J Biol Chem; 1992 Jul; 267(19):13675-80. PubMed ID: 1377690
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylcholine acts as a Ca2+-dependent receptor molecule for lymphocyte perforin.
Tschopp J; Schäfer S; Masson D; Peitsch MC; Heusser C
Nature; 1989 Jan; 337(6204):272-4. PubMed ID: 2783478
[TBL] [Abstract][Full Text] [Related]
14. Binding of human complement C8 to C9: role of the N-terminal modules in the C8 alpha subunit.
Scibek JJ; Plumb ME; Sodetz JM
Biochemistry; 2002 Dec; 41(49):14546-51. PubMed ID: 12463754
[TBL] [Abstract][Full Text] [Related]
15. Anti-idiotypic antibodies derived against C8, C9 and perforin bind homologous restriction factor.
Young JD; Jiang S; Liu CC; Hasselkus-Light CS
J Immunol Methods; 1990 Mar; 128(1):133-42. PubMed ID: 1691232
[TBL] [Abstract][Full Text] [Related]
16. Membrane attack complex proteins C5b-6, C7, C8, and C9 of human complement.
Esser AF; Sodetz JM
Methods Enzymol; 1988; 162():551-78. PubMed ID: 3226325
[No Abstract] [Full Text] [Related]
17. S-protein/vitronectin interaction with the C5b and the C8 of the complement membrane attack complex.
Su HR
Int Arch Allergy Immunol; 1996 Aug; 110(4):314-7. PubMed ID: 8768797
[TBL] [Abstract][Full Text] [Related]
18. Phylogenetic analysis of the homologous proteins of the terminal complement complex supports the emergence of C6 and C7 followed by C8 and C9.
Mondragón-Palomino M; Piñero D; Nicholson-Weller A; Laclette JP
J Mol Evol; 1999 Aug; 49(2):282-9. PubMed ID: 10441679
[TBL] [Abstract][Full Text] [Related]
19. Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage.
Sims PJ
Biochim Biophys Acta; 1983 Aug; 732(3):541-52. PubMed ID: 6871214
[TBL] [Abstract][Full Text] [Related]
20. The homologous restriction factor is immunologically related to complement components C8 and C9 and to lymphocyte pore-forming protein perforin through cysteine-rich domains.
Young JD; Rosse WF; Hasselkus-Light CS
Biochem Biophys Res Commun; 1990 Jan; 166(2):648-52. PubMed ID: 2302230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
